Short-course androgen suppression therapy prior to brachytherapy for favorable-risk prostate cancer and the risk of all-cause mortality in men with or without preexisting cardiovascular disease

被引：0
|
作者：
Hayes, J. H.
Chen, M.
Moran, B. J.
Braccioforte, M. H.
Dosoretz, D.
Salenius, S.
Katin, M.
Ross, R.
D'Amico, A. V.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Connecticut, Storrs, CT USA
[3] Prostate Canc Fdn Chicago, Westmont, IL USA
[4] 21st Century Oncol, Ft Myers, FL USA
[5] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5066
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Race and Mortality Risk After Radiation Therapy in Men Treated With or Without Androgen-Suppression Therapy for Favorable-Risk Prostate Cancer
    Kovtun, Konstantin A.
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian J.
    D'Amico, Anthony V.
    CANCER, 2016, 122 (23) : 3608 - 3614
  • [2] Race and the Risk of Death Following High-Dose Radiation Therapy in Men Treated With or Without Androgen Suppression Therapy for Favorable-Risk Prostate Cancer
    Kovtun, K.
    Chen, M. H.
    Braccioforte, M. H.
    Moran, B. J.
    D'Amico, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E402 - E402
  • [3] Duration of Short-Course Androgen Suppression Therapy and the Risk of Death As a Result of Prostate Cancer
    D'Amico, Anthony V.
    Chen, Ming-Hui
    Crook, Juanita
    Armstrong, John G.
    Malone, Shawn
    Steigler, Allison
    Dunne, Mary
    Kantoff, Philip W.
    Denham, James W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (35) : 4682 - 4687
  • [4] Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapy
    Taira, Al V.
    Merrick, Gregory S.
    Galbreath, Robert W.
    Butler, Wayne M.
    Wallner, Kent E.
    BRACHYTHERAPY, 2010, 9 (01) : 42 - 49
  • [5] Prior cancer diagnosis in men with nonmetastatic prostate cancer and the risk of prostate cancer specific and all-cause mortality
    Mirabeau-Beale, Kristina
    Chen, Ming-Hui
    D'Amico, Anthony Victor
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [6] Androgen deprivation for prostate cancer and the development of cardiovascular disease, its risk factors, and all-cause mortality.
    Maletz, K. L.
    Ennis, R. D.
    Smith, G. C.
    Kalnicki, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Factors Impacting All-cause Mortality in Men Receiving Androgen Deprivation Therapy with Prostate Brachytherapy
    Taira, A. V.
    Merrick, G. S.
    Galbreath, R. W.
    Butler, W. M.
    Adamovich, E.
    Wallner, K. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S154 - S154
  • [8] RISK OF ALL-CAUSE AND PROSTATE CANCER-SPECIFIC MORTALITY AFTER BRACHYTHERAPY IN MEN WITH SMALL PROSTATE SIZE
    Nguyen, Paul L.
    Chen, Ming H.
    Choueiri, Toni K.
    Hoffman, Karen E.
    Hu, Jim C.
    Martin, Neil E.
    Beard, Claw J.
    Dosoretz, Daniel E.
    Moran, Brian J.
    Katin, Michael J.
    Braccioforte, Michelle H.
    Ross, Rud
    Salenius, Sharon A.
    Kantoff, Philip W.
    D'Amico, Anthony V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1318 - 1322
  • [9] Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy
    Raldow, Ann C.
    Zhang, Danjie
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian J.
    D'Amico, Anthony V.
    BRACHYTHERAPY, 2015, 14 (06) : 781 - 787
  • [10] Gleason score and the risk of cause-specific and all-cause mortality following radiation with or without 6 months of androgen deprivation therapy for men with unfavorable-risk prostate cancer
    Warren, Laura E. G.
    Chen, Ming-Hui
    Denham, James W.
    Steigler, Allison B.
    Renshaw, Andrew A.
    Loffredo, Marian
    Kantoff, Philip W.
    D'Amico, Anthony V.
    JOURNAL OF RADIATION ONCOLOGY, 2016, 5 (03) : 301 - 308
12345